All stock reports

APARINDS evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-27T14:00:59.076610+00:00

Metrics

latest_annual_period
2026-03-31
revenue
229021200000.0
net_income
9769300000.0
operating_cash_flow
7013100000.0
free_cash_flow
-353500000.0
total_assets
137112900000.0
total_liabilities
83179100000.0
total_equity
53933800000.0
cash
7761900000.0
total_debt
9555100000.0
revenue_growth
0.23254190658197182
earnings_growth
0.18949226835504684
net_margin
0.04265674968081558
roe
0.18113502108139978
debt_to_equity
0.1771634856064286
cash_conversion
0.7178712906758928
free_cash_flow_margin
-0.001543525228232146
trailing_pe
56.8191
forward_pe
12.5313
peg_ratio
Not supplied
price_to_book
12.391
dividend_yield
Not supplied

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Trend Continuation Pullback

Research only. Direction: LONG.

Tests continuation after a controlled retracement within an established trend

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Price breach below slow EMA
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-824327bb9471ecf8497e31a72ee2283972dfab2b0142e2cc3d0aaddc943dfc90
Policy
stock-decisions-v1
Evidence bundle hash
63bef8972ff665519238096f48af125147a7aa02c499363e54386818e0925f28
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: b370830c2bf4f9e925cada82542a04eb1cf91c36c378c1597bbc7d394dc2813f
  • daily-price: c8d76f8dfdf093914441679e4204ed2c00d6c9e114a39d36d7386bf10756fb86
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 250-session price return was 102.75%. The cached financial metric revenue growth is 0.23254190658197182. The cached financial metric roe is 0.18113502108139978.

Risks

The closing price was -6.85% below its highest close in the available trailing year. The cached financial metric free cash flow margin is -0.001543525228232146. Average cached traded value over twenty sessions was INR 2,388,468,704. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The trailing 20-session price return was 5.33%. The trailing 60-session price return was 31.74%. The cached financial metric net margin is 0.04265674968081558. The cached financial metric debt to equity is 0.1771634856064286.

Cached observations and evidence limits